Skip to main content
. 2020 Jul 15;181:104878. doi: 10.1016/j.antiviral.2020.104878

Table 2.

Inhibitory effect of remdesivir-berberine combined treatment against SARS-CoV-2 in vitro. For each experimental condition, IC50, CC50 and the corresponding SI values are listed.

Combination treatment IC50 (μM) CC50 (μM) SI
Remdesivir 0.987 275 278.62
Remdesivir
+
Berberine 12.5 μM
0.409 264 645.47
Berberine 10.577 > 400 > 37.84
Berberine
+
Remdesivir 0.625 μM
6.95 > 57.55
Berberine
+
Remdesivir 2.5 μM
8.237 > 48.56